Aclarion, Inc. (ACON) vs InMed Pharmaceuticals Inc. (INM)
A side-by-side comparison of Aclarion, Inc. and InMed Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACON
Aclarion, Inc.
$2.34HealthcareDelayed quote: Oct 6, 2026, 12:52 PM EDT
INM
InMed Pharmaceuticals Inc.
$1.33HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT
Total return — ACON vs INM
growth of $100 · dividends reinvested · last 4yACON -100.0% (-95.1%/yr)INM -99.7% (-77.1%/yr)INM compounded faster over this window
Log scale — wide-divergence pair
ACON INM
ACON vs INM: by the numbers
- •INM is the larger company ($7M vs $7M market cap).
- •Both run net losses; INM's is the smaller (-0.61% vs -10978.48% net margin).
Metrics side by side
Valuation
| Metric | ACON | INM |
|---|---|---|
| P/S ratio | 80.52 | 0.00 |
| P/B ratio | 0.40 | 6.80 |
Profitability
| Metric | ACON | INM |
|---|---|---|
| Gross margin | -291.27% | 14.92% |
| Operating margin | -9312.55% | -0.52% |
| Net margin | -10978.48% | -0.61% |
| ROE | -54.09% | -1168.44% |
| ROIC | -57.11% | -995.44% |
Growth (annualized)
| Metric | ACON | INM |
|---|---|---|
| Revenue CAGR (5Y) | 3.75% | N/A |
| Total return CAGR (5Y) | N/A | -71.98% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.